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Abstract
Magnetic resonance imaging (MRI) is being used to probe the central nervous system (CNS) of
patients with multiple sclerosis (MS), a chronic demyelinating disease. Conventional T2-weighted
MRI (cMRI) largely fails to predict the degree of patients' disability. This shortcoming may be due
to poor specificity of cMRI for clinically relevant pathology. Diffusion tensor imaging (DTI) has
shown promise to be more specific for MS pathology. In this study we investigated the association
between histological indices of myelin content, axonal count and gliosis, and two measures of DTI
(mean diffusivity [MD] and fractional anisotropy [FA]), in unfixed post mortem MS brain using a
1.5-T MR system. Both MD and FA were significantly lower in post mortem MS brain compared
to published data acquired in vivo. However, the differences of MD and FA described in vivo
between white matter lesions (WMLs) and normal-appearing white matter (NAWM) were retained
in this study of post mortem brain: average MD in WMLs was 0.35 × 10− 3 mm2/s (SD, 0.09)
versus 0.22 (0.04) in NAWM; FA was 0.22 (0.06) in WMLs versus 0.38 (0.13) in NAWM.
Correlations were detected between myelin content (Trmyelin) and (i) FA (r = − 0.79, p < 0.001),
(ii) MD (r = 0.68, p < 0.001), and (iii) axonal count (r = − 0.81, p < 0.001). Multiple regression
suggested that these correlations largely explain the apparent association of axonal count with (i)
FA (r = 0.70, p < 0.001) and (ii) MD (r = − 0.66, p < 0.001). In conclusion, this study suggests
that FA and MD are affected by myelin content and – to a lesser degree – axonal count in post
mortem MS brain.
Introduction
Histopathologically, central nervous system (CNS) tissue of individuals with multiple
sclerosis (MS) is characterized by demyelination, axonal damage, gliosis, inflammation and
often some degree of remyelination. Whereas microscopically these features can be readily
appreciated, it has been proven difficult to distinguish them in vivo using neuroimaging
methods. T2 weighted (T2w) and gadolinium (Gd)-enhanced T1-weighted (T1w; both
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techniques often summarized as “conventional”) magnetic resonance imaging (MRI)
displays MS white matter (WM) lesions (WMLs) with high sensitivity and is helpful in
diagnosis (McDonald et al., 2001; Polman et al., 2005). Aside from a relationship between
Gd enhancement and inflammation (Hawkins et al., 1990; Katz et al., 1993), however, such
conventional MRI (cMRI) techniques do not distinguish other histopathological substrates
of MS (Moore, 2003). The inability of cMRI to reflect MS pathology in more detail may be
one of the major reasons why the correlation between cMRI measures and disability is only
modest (Kappos et al., 1999; Brex et al., 2002). Complementing cMRI, quantitative MR
measures have been developed that are potentially more pathologically specific. These
include diffusion-weighted MRI (DWI), volumetric measurements, magnetization transfer
(MT) imaging, quantitative T1- and T2-relaxation time (RT) measurements, and MR
spectroscopic metabolite concentrations (Tofts, 2003).
Increasing pathological specificity is worthwhile as it may help to (i) further elucidate the
pathogenesis of MS and (ii) monitor treatments aimed at modifying specific processes. The
investigation of post mortem tissue allows the direct assessment of the relationship between
MR measures and underlying pathology. Such experiments have so far provided insights
into the pathological correlates of several MR indices including T1 hypo-intensity (van
Walderveen et al., 1998; van Waesberghe et al., 1999; Barkhof et al., 2003), T1- (Schmierer
et al., 2004a) and T2-RT (Moore et al., 2000) and MT ratio (van Waesberghe et al., 1999;
Barkhof et al., 2003; Schmierer et al., 2004a).
DWI relies on the detection of changes in the random translational motion of water
molecules in tissue. For a comprehensive description of the motion of water molecules, the
diffusion tensor can be estimated, provided diffusion tensor MRI (DTI) is employed (Basser
et al., 1994; Le Bihan et al., 2001; Bammer et al., 2005). DTI requires the measurement of
the MR signal with diffusion sensitization along at least six non-colinear non-coplanar
directions and allows determination of three mutually perpendicular eigenvectors (indicating
the direction of the diffusion) and the corresponding eigenvalues (giving its magnitude).
Various mathematical combinations of these values provide rotationally invariant diffusion
indices (i.e., measurements that characterize a specific voxel independently of positioning in
the scanner) including mean diffusivity (MD) and fractional anisotropy (FA). The latter
describes the fact that in CNS WM, water molecules are more likely to diffuse parallel to,
rather than across, fiber tracts. The FA value increases with this anisotropy and provides a
spatial depiction of anisotropic areas, whereas MD is an index of the magnitude of water
diffusion regardless of its direction (Wheeler-Kingshott et al., 2003a).
DWI is sensitive to pathological processes that alter tissue integrity, as these may result in
changes to (i) the number and permeability of biological barriers that normally restrict the
motion of water molecules, (ii) the relative sizes of intra-cellular, extra-cellular or other
compartments, or (iii) other tissue properties affecting tissue anisotropy and diffusivity.
Using experimental allergic encephalitis (EAE), an animal model of MS, an increase in
diffusivity in MR detectable lesions has been shown to be associated with a number of tissue
alterations including fibrosis of vessel walls, interstitial edema, vacuolization, vesicular
degeneration, myelin damage (Verhoye et al., 1996), inflammatory infiltrates (Richards et
al., 1995) and blood–brain barrier leakage (Broom et al., 2005). However, reduced
diffusivity has also been observed in EAE, particularly in the lesion center with abundant
astrocytosis and densely packed macrophages (Broom et al., 2005).
DWI has been widely applied to probe MS in vivo (Horsfield and Jones, 2002; Filippi et al.,
2003; Symms et al., 2004; Rovaris et al., 2005; Bammer et al., 2005; Ge et al., 2005).
Recently, it has been suggested that DTI metrics provide a rather specific measure of axonal
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loss (Hesseltine et al., 2006). However, investigation of the pathological correlates of DWI
in MS has been scarce (Mottershead et al., 2003; Wheeler-Kingshott et al., 2003b;
Schmierer et al., 2004b; Fox et al., 2005). In this study we aimed to systematically explore
the association between quantitative histological measures of myelin content, axonal count
and gliosis and two important indices of DTI (MD and FA) in post mortem brain samples of
16 patients with MS.
Material and methods
Patients/samples
This study was approved by the Joint Ethics Committees of The National Hospital for
Neurology and Neurosurgery and the Institute of Neurology, UCL. Post mortem brain slices
of 16 patients with MS (15 women and 1 man) were provided by the UK Multiple Sclerosis
Tissue Bank (MSTB) based at Charing Cross Hospital, Imperial College School of
Medicine, London, UK. The mean age of the patients was 59 years (SD: 13 years; range:
34–82); their mean disease duration was 25 years (9; 6–43). The course of MS (Lublin and
Reingold, 1996) and the disability of the patients were assessed retrospectively from the
case records collected at the MSTB. Disability was estimated using the expanded disability
status score (EDSS) scale (Kurtzke, 1983). The brain weight and the pH of the cerebro-
spinal fluid (CSF) of each patient were provided by the MSTB.
Brains were retrieved by the MSTB a mean of 16 h (SD: 6 h; range: 7–28 h) after death. One
coronal brain slice (thickness: 1 cm) of one hemisphere in each case was used for this study.
The mean time between tissue retrieval and dissection of the brain slices was 4 h (SD: 2;
median: 4; range: 1–8); the mean time between death and MR scanning was 46 h (SD: 24;
median: 39; range: 10–107). The brain slices were stored in sealed plastic bags at 2–8 °C
until 3 h before scanning when they were taken out of the refrigerator and plastic bags,
wrapped in PVC foil to minimize dehydration and left to reach scanner room temperature.
To control for the effects of temperature on the results, the temperature of the samples was
assessed immediately after scanning using a K-type hypodermic thermocouple temperature
probe connected to a HI 93551 thermometer (Hanna Instruments Ltd., Leighton Buzzard,
UK). After measuring the temperature specimens were immersed in 10% buffered formalin
solution.
MRI
Scanning was performed on a GE Signa Horizon Echospeed 1.5-T MR system (General
Electric, Milwaukee, WI, USA). All MR sequences were acquired as a single slice
(thickness: 5 mm), which was centered parallel to the coronal surface of the specimen.
The following sequences were performed:
(i) 2D spin echo (SE) T1w; repetition time [TR] 540 ms; echo time [TE] 18 ms; and
dual SE proton density (PD), and T2w (TR 2000; TE 30 and 120 ms; flip angle
90°, matrix size 256 × 256). All these sequences were acquired twice, once with
a field of view [FOV] of 300 × 300 mm2 (to allow visualization of fiducial
markers of the custom-built sample support, see further below), and again with a
FOV of 240 mm × 180 mm giving better resolution of anatomical structures and
lesions.
(ii) multi-shot diffusion-weighted spin echo EPI (TR/TE: 3000 ms/86 ms). The
gradient b factor was 1940 s/mm2, number of shots = 8, number of
excitations = 4 (acquired separately), FOV = 12 × 12 cm2, matrix 48 × 48
(reconstructed as 64 × 64) resulting in a pixel size of 2.5 × 2.5 mm2
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(reconstructed 1.9 × 1.9 mm2). For each shot and average, six diffusion-
weighted images along six non-colinear directions, and one non-diffusion-
weighted (b = 0) image (i.e., with b = 0) were acquired. The directions of the
diffusion weighting were selected to apply maximum gradient strength along
two axes at a time and to obtain a high b factor without increasing TE or loosing
signal-to-noise. The scheme used was (0 0 0, 1 1 0, 1 0 1, 0 1 1, − 1 1 0, − 1 0 1,
0 − 1 1). Data were processed to determine the diffusion tensor on a pixel-by-
pixel basis on each slice. Magnitude images of each slice were reconstructed and
averaged off-line, prior to being processed to determine the diffusion tensor on a
pixel-by-pixel basis. MD and FA were calculated from the principal diffusivities
of the diffusion tensor (Wheeler-Kingshott et al., 2003b). Note that high b
values (reducing signal-to-noise) were necessary because of the different range
of the apparent diffusion coefficient in post mortem brain.
All scans and maps were displayed on a Sun workstation (Sun Microsystems, Mountain
View, CA, USA) using DispImage (Plummer, 1992). Regions of interest (ROIs) were
defined and labeled on the T2w scans, as follows: (i) areas of hyper-intense signal suspected
to be MS WMLs and (ii) two to three regions of normal-appearing white matter (NAWM).
ROIs on T2w scans were inherently registered with their respective T1w images. Due to the
difference in geometrical distortions, however, the position of the ROIs on b = 0 scans had
to be determined visually with reference to the corresponding T2w images. The ROIs on
b = 0 images were then marked and co-registered with the MD and FA maps.
In order to optimize correspondence between ROIs defined on MRI with their pathological
substrate in the specimens a stereotactic procedure (StP) was employed (Schmierer et al.,
2003). T1w, T2w, and PD images acquired with a FOV of 300 × 300 mm2 were used to
determine the co-ordinates of (i) the ROIs (with reference to the images acquired with a
FOV of 240 mm × 180 mm) and (ii) the fiducial points of the localizer of the stereotactic
system. The co-ordinates obtained at the scanner were then processed using the
StereoCalc™ program (Radionics, Burlington, MA, USA) mounted on a laptop computer to
give the co-ordinates that allowed – in the dissection theatre – the pointer of a Cosman–
Roberts–Wells arc system (Radionics, Burlington, MA, USA) to be guided towards the
target points (i.e., the ROIs) in the specimen. Every target point was then marked with a
small dot of tissue dye on the surface of the specimen. In nine/16 specimens the entire MR
and StP protocol was performed in one session before fixation of the tissue. In seven/16
cases StP had to be performed following a separate MR session after the tissue had been
fixed as previously described (Schmierer et al., 2003).
Pathological and morphometric procedures
Tissue blocks of approximately 1.5 cm × 1.5 cm × 1 cm in volume and centered on each
ROI were dissected. The blocks were then cut in half using a 5 mm deep iron angle resulting
in two blocks of equal thickness with the cut surface corresponding to the center of the MR
imaging plane. All dissected blocks were marked with notches at known positions, usually
on the ventral and lateral cut surfaces, in order to assure the orientation in space after further
processing. Blocks were processed for embedding in paraffin. Sections were stained with
hematoxylin and eosin (H and E), Luxol fast blue (LFB), and Bielschowsky’s silver
impregnation. Immunocytochemistry included antibodies to glial fibrillary acidic protein
(GFAP, 1/1500) and CD68 (1/100; both from Dako, Glostrup, Denmark) Fig. 1.
Histologically, MS WMLs were defined in comparison to surrounding NAWM as clearly
distinct, sharply demarcated areas of (i) essentially lost staining for LFB (demyelinated
WMLs) or (ii) uniformly thin myelin sheathing (in relationship to axon diameter), which
occurs either throughout the WML (fully remyelinated “shadow” plaque) or at the edge of
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an otherwise demyelinated WML (partially remyelinated plaque) (Prineas et al., 2002;
Barkhof et al., 2003; Brück et al., 2003). The minimum area of remyelination required for a
WML to be considered partially remyelinated was 10% of the whole WML (Schmierer et
al., 2004a). Lesion stage was categorized as either early active (EA: inflammation
throughout the WML), chronic active (CA: hypocellular center, inflammation only at the
rim of the WML), or chronic inactive (CI: no inflammation) (Fig. 1) (Trapp et al., 1998; van
der Valk and de Groot, 2000).
Axon counts were estimated on Bielschowsky-stained slides, by a stereological method
using a 21 bar (bar length: 13 μm) quadrate grid graticule (size: 160 × 160 μm2) and a final
magnification of × 1250. Random points were superimposed over WMLs and surrounding
NAWM. On each slide the total number of bars intersecting axons was counted in 12–16
areas of both the WML and surrounding NAWM (Brück et al., 1997). The counts were then
averaged for each WML and respective NAWM ROI.
Myelin content was quantified in WML and NAWM by assessing transmittance (Tr),
defined as the transmitted light divided by the incident light, on LFB-stained sections using
a Leica Q500MC digital image analyzer with a 256 grey scale resolution (Leica Cambridge
Ltd., UK), which was mounted on a Zeiss photomicroscope 3 (Carl Zeiss, Jena, Germany).
The program was set in RGB mode, the white level was kept constant at 75% of the
maximum, and a final magnification of × 125 was used. Within every ROI (i.e., a WML or
an equally sized region of NAWM adjacent to a WML) the light intensity was assessed in
three to five random areas using a field size of 400 × 385 μm. The values obtained from
each area were averaged, and then divided by the light intensity transmitted through the
object slide (away from the tissue section) to result in the Trmyelin values for WMLs and
NAWM (Mize et al., 1988; Gentleman et al., 1999; Schmierer et al., 2004a, b). A high value
of Trmyelin reflects low myelin content.
Gliosis in WMLs and NAWM was classified on GFAP-stained slides (i) by visual inspection
as mild, moderate, or severe, and (ii) quantitatively in WMLs and surrounding NAWM by
light transmittance in the same manner as for myelin content and expressed as Trgliosis. A
low value of Trgliosis reflects more severe gliosis than a high Trgliosis.
The thickness of LFB- and GFAP-stained sections was assessed using a stereological
microscope and a final magnification of × 787.5, in order to control for possible effect of
section thickness on the measurements of Tr. On each slide, three to five measurements
were performed and averaged.
Statistical methods
Of the majority of MS cases used for this study more than one tissue block was included in
the analysis. Tissue blocks could therefore not be analyzed as independent observations, i.e.,
without taking into account within-patient dependency. We addressed this “data hierarchy”
by analyzing correlation either (a) between patients, (b) within patients or (c) a combination
of (a) and (b) taking into account lack of independence.
Two methods were used to compare means: (i) to compare means of variables in WMLs
versus NAWM there was insufficient within-patient variability. Hence, between-patient
comparisons are being reported in that paired t-tests were carried out on patient means
averaged across their respective tissue sample. (ii) To compare means between demyelinated
and remyelinated WMLs (dWMLs and rWMLs, respectively) it was possible to use a
combination of between- and within-subject information. The underestimated standard error
and p values that would have resulted using a simple t-test were inflated by using linear
regression according to the Huber–White method (Huber, 1967) for inflating standard error,
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which resulted in correctly estimated p values. The same approach was not possible to test
for correlation between MRI and pathology indices, as there was insufficient between-
patient variability to sustain consistent use of between-patient information. Therefore,
within-patient correlation was obtained using Pearson correlation coefficients estimated
from fixed patient intercept regression (Baltagi, 1995), which ignores between-patient
differences and fits an estimated average regression slope to each patient's sample (the
within-patient correlation measures the strength of the correlation in tissue samples
belonging to the same patient).
Potential confounding by slide thickness or batch was investigated by adding these terms to
regression models where appropriate (for slide batch, potential confounding is not applicable
to within-subject results, all of which were in the same batch). Variation with batch was
assessed using a random intercept model to allow for within- and between-patient
variability, with restricted maximum likelihood estimation. Where there was doubt
concerning normality of model residuals, estimates were checked against those from a non-
parametric bias-corrected bootstrap with 1000 replicates (Carpenter and Bithall, 2000), and
validity was confirmed. Analyses were carried out using Stata 9.0 (Stata Corporation,
College Station, TX, USA).
Results
The clinical course had been secondary progressive in ten subjects and primary progressive
in two. In four subjects, the clinical course could not be determined (Table 1). The estimated
mean EDSS was 8 (SD: 1; median: 8.5; range: 6.5–9). The mean brain weight was 1131 g
(SD: 113 g, range: 1000–1310 g). The pH of the CSF was 6.9 (SD: 0.4, range: 6.5–7.5). The
mean temperature of the tissue during MRI was 22.3 °C (SD: 2.6 °C, range: 17.5–25.1 °C).
Lesion findings
Seventy-five regions of high signal (RHS) thought to be MS WMLs were detected on T2w
MRI. Twenty-five/75 RHS had to be discarded from further analysis due to (i) poor in-plane
co-registration between MRI and specimen (6), (ii) poor identification of different tissue
components on histology (5), (iii) misidentification of a vascular lesion (1) or NAWM (10)
as WMLs, and (iv) other technical problems (3).
Of the remaining 50 WMLs, a further 12 had to be discarded because no clear
correspondence could be determined between the T2w MRI and b = 0 map (Fig. 2). Hence,
38 histologically confirmed WML, visible on T2w MRI as well as b = 0 images were
studied. Between one and six WMLs in each brain slice (mean 2.4 WMLs; SD: 1.4 WMLs)
could be used for the analysis. Quantitative MR values were also obtained in two to three
regions of NAWM in each slice and then averaged.
Twenty-eight/38 WMLs (73.7%) were demyelinated, three were fully remyelinated (7.9%)
and seven partially remyelinated (18.4%) (Table 1). Two/38 (2.6%) WMLs were classified
as early active, nine (23.7%) as CA, and 27 (71.1%) as CI WMLs. All (fully or partially)
rWMLs were CI WMLs.
Twenty-two/38 WMLs (57.9%) were hypo-intense and 16/38 (42.1%) iso-intense on T1w
MRI. Fully rWMLs (shadow plaques) represented two/22 (9.1%) T1 hypo-intense WMLs
and 1/16 (6.25%) T1 iso-intense WMLs. Partially remyelinated WMLs contributed three/22
(13.6%) T1 hypo-intense WMLs and four/16 (25%) T1 iso-intense WMLs.
Fibrillary gliosis was classified in 35/38 WMLs and observed as being moderate in five/35
(14.3%), and severe in 30/35 (85.7%) WMLs.
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Comparison of MS lesions and NAWM
MD, FA, myelin content (Trmyelin), axonal count and gliosis (Trgliosis) all differed
significantly between WMLs and NAWM. Results were similar when the analysis was
restricted to (partially or fully) rWMLs versus NAWM: rWMLs displayed significantly
higher MD, more pronounced gliosis and lower FA, myelin content and axonal count (Table
2).
Correlation of MR diffusion and pathology
Myelin content (Trmyelin) correlated with FA (r = − 0.79, p < 0.001) and MD (r = 0.68,
p < 0.001). A similarly strong correlation was detected between axonal count and both FA
(r = 0.70, p < 0.001) and MD (r = − 0.66, p < 0.001). A weaker correlation emerged
between both MD and gliosis (r = − 0.55, p = 0.002) and FA and gliosis(r = 0.50, p = 0.004)
(Table 3, Fig. 3).
Correlation between neuropathological features
Myelin content (Trmyelin) was strongly associated with axonal count (r = − 0.81, p < 0.001)
(Table 2, Fig. 4). Both Trmyelin and axonal count were moderately associated with Trgliosis.
More severe gliosis correlated with lower myelin content and a smaller axonal count (Table
3).
Regression analysis of confounding correlations
Predicting myelin content—The univariate correlation of Trmyelin with FA (− 0.79,
p < 0.001) is reduced to partial correlation − 0.65, p < 0.001 after adjustment for MD. The
univariate correlation between Trmyelin and MD (r = 0.68, p < 0.001) is reduced to partial
correlation 0.43, p = 0.019 after adjusting for FA.
These results suggest that FA and MD are independently associated with Trmyelin. The
correlations remain robust when adjusting for section thickness of the LFB-stained slides.
Predicting axonal count—The univariate correlation between axonal count and FA
(0.70, p = 0.001) is substantially reduced and no longer significant when adjusted for
Trmyelin (partial r = 0.16; p = 0.399). Albeit reduced, the association between axonal count
and FA remains significant after adjustment for Trgliosis (partial r = 0.57, p = 0.001).
The univariate correlation between axonal count and MD is substantially reduced and no
longer significant after adjustment for Trmyelin (partial r = − 0.24; p = 0.212). The
association between axonal count and MD remains significant after adjustment for Trgliosis
(partial r = 0.51, p = 0.005).
Together, these results suggest that the correlations of axonal count with both FA and MD
are not independent of the (strong) correlation between axonal count and Trmyelin, but
unrelated to the severity of gliosis. In a post hoc analysis box-plots were produced to further
illustrate the relationships between FA, myelin content and axonal count (Fig. 5).
Predicting gliosis—We were unable to assess whether the univariate association between
Trgliosis and FA (r = 0.50, p < 0.01) is independent of Trmyelin, as neither association is
significant in a model with both. Nor has it been possible to assess whether the association
between Trgliosis and MD (r = − 0.55, p < 0.01) is independent of Trmyelin.
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Comparison of demyelinated and remyelinated lesions
dWMLs had ∼ 60% lower axonal count (p = 0.029) and a trend for higher MD (p = 0.061)
and lower FA (p = 0.167) than rWMLs (Table 2).
Other histopathological lesions subgroups
No significant differences in MD or FA were seen between CA and CI WMLs or between
T1 hypo-intense and iso-intense WMLs. There were too few EA WMLs to investigate this
lesion category.
None of the described relationships was substantially affected by estimated EDSS, age,
disease duration, time between death and tissue retrieval, or time between death and MRI.
Batch and section thickness
The mean thickness of the histological sections was 9.4 μm (SD: 3.6 μm), and 4.8 μm (SD:
0.7 μm) for LFB- and GFAP-stained samples, respectively. Staining of the samples for LFB
and GFAP was performed in nine and six batches, respectively. Trmyelin in WMLs did not
vary with batch, but significant batch variation was seen for Trmyelin in NAWM (p < 0.001),
and borderline significance variation for Trgliosis in WMLs and NAWM. None of the
observed pathology–MR correlations were affected by including section thickness and batch
in the regression analysis (correlation coefficients were altered by no more than ± 0.01,
± 0.05 and significant p values by not more than ± 0.001, ± 0.002 when adjusting for batch
and thickness, respectively).
Discussion
Pathological correlations of the MR measures
This study revealed strong univariate correlation of myelin content as well as axonal content
with MD and FA in chronic post mortem MS brain. Multivariate analysis of our data,
however, suggests that both indices MD and FA are primarily affected by myelin content,
whereas their correlation with axonal count is largely explained by the strong association of
the latter with myelin content. This finding challenges the concept that an increase in MD
and decrease in FA of WMLs and/or NAWM necessarily indicate the presence of axonal
loss (Hesseltine et al., 2006) in patients with progressive MS: on the contrary, the findings
suggest that loss of myelin per se is sufficient to produce a significant change in both of
these diffusion measures. Caution is therefore recommended in using either MD or FA to
make inferences on axonal integrity per se.
Both, MD and FA as well as myelin content, axonal count and the severity of gliosis were
clearly different between WMLs and NAWM. These differences were also robust in the
subgroup of rWMLs versus NAWM, though only marginal evidence emerged for a
difference of MD (and even less so for FA) between rWMLs and dWMLs. This may be due
to the limited sample size: whereas in the analysis of rWMLs versus NAWM all rWMLs
could be included (of all cases in which rWMLs were detected areas of NAWM were
available for comparison), only cases with both lesion types were included in the analysis of
rWMLs versus dWMLs. Compared to WMLs the standard deviation of FA was larger in
NAWM; FA in the former may have been consistently low due to most WMLs exhibiting
complete demyelination, whereas in the NAWM, FA may vary considerably depending on
the orientation of fiber pathways and bundles in the ROI.
The extent of fibrillary gliosis correlated moderately with higher MD and lower FA. This
correlation, however, was not independent of the correlation of MD and FA with myelin
content (and axonal count). Hence, our data suggest that in chronic post mortem MS brain
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MD and FA appear to be mainly affected by a loss of structure due to demyelination and –
to a lesser degree axonal loss – resulting in larger intercellular spaces (Barnes et al., 1991;
Larsson et al., 1992; Werring et al., 1999). Histologically, the network of gliotic fibers
appears to restrict the disorganization that would result from demyelination and axonal
damage alone, and it has been suggested that this “repair” mechanism (fibrillary gliosis)
thereby limits the magnitude of MD and FA alterations in MS brain (Rovaris et al., 2005).
Our data suggest, however, that the potential to quantify this effect using indices of MR
diffusion may be limited, at least in post mortem MS brain: in univariate correlation, more
severe gliosis was actually correlated with a higher MD, although this apparent association
is probably secondary to the correlation between gliosis and demyelination.
No difference was detected in this study for any quantitative index (MRI, histology)
between CA and CI WMLs (Fig. 1) suggesting that the extent of inflammation in chronic
post mortem MS brain tissue may have a minor effect on measures of MR diffusion.
However, the number of histopathologically active WMLs in this sub-study was small, and
the overall sample biased towards the late chronic stage of MS with limited inflammatory
activity of WMLs. In vivo studies in patients with MS suggested that compared to chronic
WMLs, MD is significantly higher and FA lower in acute (Gd-enhancing) WMLs (Werring
et al., 1999; Roychowdhury et al., 2000), though published results have been equivocal in
this respect (Rovaris et al., 2005). More EA and CA WMLs will have to be sampled to
further elucidate the significance of inflammation for MD and FA changes in MS brain.
With cautious reference to post mortem changes of diffusivity in autopsy tissue (see below)
our study suggests that in patients with MS MD and FA both primarily reflect myelin
content, while axonal damage and (to a lesser degree) gliosis may also affect these two
measures of DTI. As our sample was limited to chronic post mortem MS brain, no
conclusions can be drawn about (i) the possible effect of early inflammatory changes and (ii)
changes in the NAWM per se on MD and FA.
Methodological aspects of the study
Compared to published values acquired during an in vivo study of MS patients using the
same MR system (Werring et al., 1999), the present post mortem study exhibits reduction in
average MD in NAWM of ∼ 75% (0.22 versus 0.88 × 10− 3 mm2/s) and in WMLs of ∼ 60%
(0.35 versus 1.11 × 10− 3 mm2/s); the reduction in average FA is ∼ one-third in NAWM
(0.38 versus 0.56) and ∼ 56% in WMLs (0.22 versus 0.50). These decreases likely reflect
several factors, including dehydration of post mortem tissue, the lower temperature during
post mortem MRI, and the breakdown of energy-dependent ion transport mechanisms
resulting in a net influx of water into cells—thereby reducing the extra-cellular space (Le et
al., 1992; Lee et al., 1998; Gass et al., 2001). The reduction in diffusivity of brain tissue
following death is a well-recognized phenomenon. In cats the diffusion coefficient
compared to pre mortem values dropped by up to 10% within 3 min and by up to 50%
within 15 min following death (Moseley et al., 1991). A similar decrease of the diffusion
coefficient post mortem has been reported in rats (Wheeler-Kingshott et al., 2000). Due to
ethical and logistical issues involved in the handling of human post mortem brain (Bö et al.,
2004) it is difficult to systematically establish, in human brain specimens, early post mortem
changes (i.e., within the first few hours after death) per se of MR diffusion. In our sample,
including time between death and MRI as a covariate in the analysis revealed no systematic
drift of the acquired data. Nevertheless, the effects of temperature, post mortem time and
tissue decay need to be kept in mind when trying to infer likely in vivo changes from data
obtained from post mortem tissue. It is noteworthy that in a study of mouse brain diffusion
anisotropy indices remained virtually unchanged when images were acquired immediately
after death (Sun et al., 2003), and minimizing the post mortem time should provide a closer
approximation to the in vivo state. Nevertheless, the differences in MD and FA that are seen
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between WMLs and NAWM in vivo (higher MD and lower FA in WMLs) were clearly
retained in this post mortem study; the observations therefore allow inferences to be drawn
concerning the pathological substrates of diffusion abnormalities in MS in vivo.
In order to take account of the reduced diffusivity in post mortem brain samples and to
improve the quality of DTI maps, the MR acquisition had to be optimized differently from
an in vivo protocol. Susceptibility artefacts were reduced by introducing a multi-shot
(instead of a single-shot) EPI protocol, and a b factor of 1940s/mm2 (i.e., almost twice as
that used in optimized in vivo protocols), was chosen to accommodate for the reduced
diffusivity in post mortem tissue. These measures allowed the acquisition of images and
maps (Fig. 2) of reasonable quality. An even greater b factor of ∼ 4000s/mm2 would be
desirable to further increase the sensitivity to white matter changes at low FA values (Jones
et al., 1999).
Throughout this study we have focused on the investigation of MS white matter. In our
experience it is sometimes difficult to unequivocally distinguish in post mortem brain
between grey and white matter, particularly when the distinction between the cortex and
white matter is concerned. This may, at least in part, be due to volume averaging (Moore,
2003). The use of an inversion recovery experiment may help to achieve better contrast
between grey and white matter in post mortem brain (Geurts et al., 2005). However, this MR
modality has not been applied in the current study.
Compared to scanning brain slices, MRI of the whole post mortem brain (Newcombe et al.,
1991) may have some advantages, including better three-dimensional anatomic relationships
and landmarks, less dehydration and – if scanned in situ – fewer susceptibility artefacts due
to retained CSF (Bö et al., 2004). Moreover, the brain in situ may decay more slowly due to
the “sterile” encapsulation of the brain in the skull, though microbial contamination is only
one among several factors (including post mortem time, temperature and humidity) with
influence on tissue degradation. Apart from the limited availability of whole brains for
individual research projects, considerably more logistical efforts, time and resources are
required to set up a “whole-corpse” imaging protocol (Bergers et al., 2002), and it may be
difficult to achieve optimum correspondence between the MR scans and their pathological
correlates (Bö et al., 2004), though results from studies using marmosets are encouraging
(Hart et al., 1998).
Future areas for MRI–pathology study in MS
Other quantitative MR measures that have been investigated previously using post mortem
MS brain include MT ratio (van Waesberghe et al., 1999; Barkhof et al., 2003; Schmierer et
al., 2004a), T1 hypo-intensity (van Walderveen et al., 1998; Barkhof et al., 2003; Schmierer
et al., 2004a), T1-RT (Schmierer et al., 2004a) and T2-RT (Moore et al., 2000). All have
been associated with myelin in MS brain with evidence for MT ratio being closely related
(Barkhof et al., 2003; Schmierer et al., 2004a). The reliability of post mortem observations
of MT ratio and T1-RT has been enhanced by their apparent stability for up to 36 h post
mortem compared to published in vivo data (Schmierer et al., 2004a). With FA and MD also
appearing to reflect myelin content and – to some degree – axonal loss, further research is
needed to seek more specific quantitative MR measures of both axonal loss and myelin
content per se. Since axonal loss is the likely pathological substrate of irreversible and
progressive disability in MS – whereas demyelination alone has potential to allow functional
and structural recovery (through restoration of nerve conduction and remyelination,
respectively (Smith et al., 2006)) – there is a pressing need for a more specific axonal
marker.
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Recent studies using animal models suggested that measures of directional diffusivity other
than FA may be able to distinguish between axonal degeneration (increased axial diffusivity;
normal radial diffusivity) (Song et al., 2003) and loss of myelin per se, at least in the early
phase of myelin breakdown (increased radial diffusivity; normal axial diffusivity) (Song et
al., 2002). These studies used longitudinally aligned structures such as the optic nerve (Song
et al., 2003), the corpus callosum (Song et al., 2005; Sun et al., 2006) and the spinal cord
(Kim et al., 2006). It may be worthwhile to also investigate the radial and axial diffusivities
of these and similar structures in post mortem MS brain.
Further research should also investigate the pathological correlates of MR tractography
obtained from DTI data sets in post mortem MS brain tissue. MR tractography is a relatively
novel application of DTI, which may have potential in quantifying the degree of nerve fiber
damage and loss in MS (Ge et al., 2005; Lin et al., 2005) and other conditions such as
amyotrophic lateral sclerosis (Ciccarelli et al., 2006). Longitudinal brain structures including
the optic nerve, spinal cord or corpus callosum may be most appropriate to investigate the
quantitative pathological correlates of MR tractography in MS brain.
Conclusion
In a post mortem study of subjects with progressive MS and chronic WMLs, we have found
a strong correlation of two standard diffusion measures – MD and FA – with myelin content
and – to a lesser degree – axonal count. MD and FA appear in the present study to be useful
indicators of demyelination in MS. Further work might usefully apply a similar multivariate
analysis approach – as in the present study – to investigate these and other potential MR
markers for their specificity in quantifying both myelin content and axonal count.
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Fig. 1.
Correlation of MRI and histopathology in post mortem multiple sclerosis brain (same case as
in Fig. 2). On the T2-weighted scan of a coronal brain slice seven exemplary regions of
interest (marked in orange) were identified as either normal-appearing white matter
(NAWM) or white matter lesions (WMLs). Three WMLs are matched to respective
histopathological sections, which were stained for hematoxylin and eosin (H&E), Luxol fast
blue (LFB), CD68, glial fibrillary acid protein (GFAP) and Bielschowsky silver
impregnation. Sections A–F illustrate a demyelinated WML with moderate infiltration by
CD68-positive cells indicating chronic inflammatory activity (chronic active WML), and an
axonal loss of 74% (compared to NAWM). Sections G–L show a hypo-cellular
demyelinated lesion with very little inflammatory activity (chronic inactive WML). Axonal
loss in this WML was 93%. Sections M–R show a remyelinated WML again with very little
inflammatory activity (remyelinated WML) and an axonal loss of only 42%. Due to their
high magnification (× 1250) images of Bielschowsky stained sections were divided into two
halves (WML on the left and NAWM on the right). All other sections cover WMLs (red
asterisks) as well as NAWM (green asterisks). MD = mean diffusivity × 10− 3 [mm2/s];
FA = fractional anisotropy.
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Fig. 2.
T2-weighted (T2w) MRI, b = 0, mean diffusivity (MD) and fractional anisotropy (FA) maps
of post mortem multiple sclerosis brain. On T2w MRI of a coronal brain slice, seven
exemplary regions of interest (ROI; marked in orange) were identified as either normal-
appearing white matter (NAWM) or white matter lesions (WMLs). ROIs were visually
matched with respective ROI on b = 0 images, and then co-registered to the MD and FA
maps. One of the five WMLs seen on T2w MRI (asterisk) could not be detected on diffusion
maps.
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Fig. 3.
Correlation between diffusion indices and quantitative histology in post mortem multiple
sclerosis brain (white matter lesions, normal-appearing white matter). The plots illustrate the
association of fractional anisotropy (FA) and mean diffusivity (MD) with (i) transmittance
of sections stained for Luxol fast blue (Trmyelin, inversely proportional to myelin content),
(ii) transmittance of sections immuno-stained for glial fibrillary acidic protein (Trgliosis,
inversely proportional to severity of gliosis) and (iii) axonal count. See Table 3 for
correlation coefficients.
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Fig. 4.
Correlation between transmittance (Tr) of sections stained for Luxol fast blue (Trmyelin,
inversely proportional to myelin content) and axonal count in post mortem multiple sclerosis
brain (white matter lesions, normal-appearing white matter).
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Fig. 5.
Box-plots of fractional anisotropy (FA) in regions of interest (ROIs) with (A) low myelin
content (i.e., high transmittance of sections stained for Luxol fast blue, Trmyelin) and (B)
high axonal count. ROIs with low myelin content and high axonal count are those below and
above the respective means over all ROIs. ROIs with low myelin content are shown divided
into those with low and high axonal counts: no difference in FA is evident between these
subgroups (p = 0.49). ROIs with high axonal counts are shown divided into those with high
and low myelin content: ROIs with high myelin content have a higher FA than ROIs with
low myelin content (p < 0.01).
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Table 1
Overview of patients and lesion characteristics in post mortem brain slices of 16 patients with multiple
sclerosis (38 white matter lesions, WMLs)
Course n patients n white matter lesions
T2w T1w [percent of T2w] dWMLs rWMLs Partially rWMLs EA CA CI
SP 10 24 12 [50] 16 3 5 0 5 19
PP 2 4 3 [75] 3 0 1 2 0 2
Unclear 4 10 7 [70] 9 0 1 0 4 6
SP = secondary progressive MS; PP = primary progressive MS; T2w = T2 weighted; T1w = T1 weighted; dWMLs = demyelinated WMLs;
rWMLs = remyelinated WMLs; EA = early active; CA = chronic active; CI = chronic inactive.
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Table 2
Comparison (means, standard deviations, p values) of (i) white matter lesions (WMLs) versus normal-
appearing white matter (NAWM), (ii) remyelinated WMLs (rWMLs) versus NAWM and (iii) demyelinated
WMLs (dWMLs) versus rWMLs in post mortem brain of patients with multiple sclerosis
WMLs (n = 38) NAWM (n = 16) p rWMLs (n = 7)a NAWM (n = 2)a p dWMLs (n = 5) rWMLsb (n = 3) p
MD 0.35 (0.09) 0.22 (0.04) < 0.01 0.31 (0.07) 0.22 (0.03) 0.01 0.51 (0.12) 0.33 (0.10) 0.06
FA 0.22 (0.06) 0.38 (0.13) 0.01 0.23 (0.07) 0.38 (0.16) 0.01 0.19 (0.05) 0.24 (0.08) 0.17
Trmyelin 0.85 (0.09) 0.45 (0.10) < 0.01 0.77 (0.07) 0.43 (0.12) < 0.01 0.87 (0.04) 0.80 (0.06) < 0.01
Axonal count 8.3 (5.1) 18.7 (2.0) < 0.01 11.3 (4.8) 18.9 (2.5) 0.01 3.5 (1.7) 9.2 (0.4) 0.03
Trgliosis 0.76 (0.04) 0.80 (0.03) 0.08 0.75 (0.05) 0.80 (0.02) 0.05 0.76 (0.02) 0.79 (0.03) 0.59
MD = mean diffusivity [× 10− 3 mm2/s], FA = fractional anisotropy; Trmyelin = transmittance of slides stained for Luxol fast blue;
Trgliosis = transmittance of slides immuno-stained for glial fibrillary acidic protein.
a
rWMLs were detected in two cases only.
b
All fully remyelinated (i.e., shadow plaques).
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Table 3
Correlationsa between indices assessed in post mortem brain of patients with multiple sclerosis
Pearson r* (n regions/n patients)
MD FA Trmyelin Axonal count
FA − 0.62 (51/16)
Trmyelin 0.68 (45/15) − 0.79 (45/15)
Axonal count − 0.66 (44/15) 0.70 (44/15) − 0.81 (44/15)
Trgliosis − 0.55 (45/15) 0.50 (45/15) − 0.51 (45/15) 0.62 (44/15)
MD = mean diffusivity; FA = fractional anisotropy; Trmyelin = transmittance of slides stained for Luxol fast blue; Trgliosis = transmittance of
slides immuno-stained for glial fibrillary acidic protein.
a
Within-patient Pearson correlation coefficients.
*
p Value of all correlations was <0.01
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